Granules India
Update in progressGRANULES.NS (NSE)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and finished dosage forms (FDs) for markets in India and abroad. It offers paracetamol, metformin, guaifenesin, and methocarbamol, along with prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, liquids, and powders, and provides peptide and amino acid derivative manufacturing. Based in Hyderabad, it was incorporated in 1984.
Company score
- Sentiment
- 0.31
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.01
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- -0.51
- Governance
- -0.90
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- -0.34
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- -0.02
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!